|
ZNF26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.224800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.003100E-04 |
| Normal-vs-Stage2 |
1.096290E-03 |
| Normal-vs-Stage3 |
6.439500E-04 |
| Normal-vs-Stage4 |
8.058400E-02 |
| Stage1-vs-Stage2 |
4.505800E-01 |
| Stage1-vs-Stage3 |
6.307400E-01 |
| Stage1-vs-Stage4 |
3.063000E-01 |
| Stage2-vs-Stage3 |
7.280400E-01 |
| Stage2-vs-Stage4 |
2.095800E-01 |
| Stage3-vs-Stage4 |
2.389600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.849900E-04 |
| Normal-vs-AfricanAmerican |
1.838410E-02 |
| Normal-vs-Asian |
6.448200E-02 |
| Caucasian-vs-AfricanAmerican |
9.027600E-01 |
| Caucasian-vs-Asian |
2.090200E-01 |
| AfricanAmerican-vs-Asian |
4.289800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.335000E-03 |
| Normal-vs-Female |
3.151300E-04 |
| Male-vs-Female |
5.077000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.975800E-04 |
| Normal-vs-Age(41-60Yrs) |
6.643700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.596300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.746500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.028200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.373800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.061400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.468400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.183200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.268800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.548300E-02 |
| Classical-VS-Follicular |
1.113790E-01 |
| Classical-VS-Other |
5.737600E-01 |
| Classical-VS-Normal |
5.215700E-03 |
| Tall-VS-Follicular |
6.110800E-01 |
| Tall-VS-Other |
3.201200E-01 |
| Tall-VS-Normal |
5.429300E-04 |
| Follicular-VS-Other |
3.614000E-01 |
| Follicular-VS-Normal |
8.821800E-04 |
| Other-VS-Normal |
5.911800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.88750000000138E-05 |
| Normal-vs-N1 |
5.946400E-02 |
| N0-vs-N1 |
2.378800E-01 |
|
|
